Human islet amyloid polypeptide‐induced β‐cell cytotoxicity is linked to formation of α‐sheet structure
Protein Science · 2024
DOI: 10.1002/pro.4854 ↗Kurz gefasst
Fachartikel in der Zeitschrift Protein Science, 2024. Verfasst von Cheng-Chieh Hsu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, University of Washington, Seattle, Washington, USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Insulin-Secreting Cells. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: BLRD VA, NIBIB NIH HHS, NIH HHS.
Abstract (Originalsprache)
Type 2 diabetes (T2D) results from insulin secretory dysfunction arising in part from the loss of pancreatic islet β‐cells. Several factors contribute to β‐cell loss, including islet amyloid formation, which is observed in over 90% of individuals with T2D. The amyloid is comprised of human islet amyloid polypeptide (hIAPP). Here we provide evidence that early in aggregation, hIAPP forms toxic oligomers prior to formation of amyloid fibrils. The toxic oligomers contain α‐sheet secondary structure, a nonstandard secondary structure associated with toxic oligomers in other amyloid diseases. De novo, synthetic α‐sheet compounds designed to be nontoxic and complementary to the α‐sheet structure in the toxic oligomers inhibit hIAPP aggregation and neutralize oligomer‐mediated cytotoxicity in cell‐based assays. In vivo administration of an α‐sheet design to mice for 4 weeks revealed no evidence of toxicity nor did it elicit an immune response. Furthermore, the α‐sheet designs reduced endogenous islet amyloid formation and mitigation of amyloid‐associated β‐cell loss in cultured islets isolated from an hIAPP transgenic mouse model of islet amyloidosis. Characterization of the involvement of α‐sheet in early aggregation of hIAPP and oligomer toxicity contributes to elucidation of the molecular mechanisms underlying amyloid‐associated β‐cell loss.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bioengineering, University of Washington, Seattle, Washington, USA.
- Molecular Engineering Program, University of Washington, Seattle, Washington, USA.
- Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, VA Puget Sound Health Care System and University of Washington, Seattle, Washington, USA.
- Department of Biochemistry, University of Washington, Seattle, Washington, USA.
Förderung
- BLRD VA
- NIBIB NIH HHS
- NIH HHS
- NIDDK NIH HHS
- NIGMS NIH HHS
- American Diabetes Association
- National Institutes of Health
- U.S. Department of Veterans Affairs
Zitieren
APA
Hsu, C. C., Templin, A. T., Prosswimmer, T., Shea, D., Li, J., Brooks-Worrell, B., Kahn, S. E., & Daggett, V. (2024). Human islet amyloid polypeptide‐induced β‐cell cytotoxicity is linked to formation of α‐sheet structure. Protein Science. https://doi.org/10.1002/pro.4854
Vancouver
Hsu CC, Templin AT, Prosswimmer T, Shea D, Li J, Brooks-Worrell B, et al. Human islet amyloid polypeptide‐induced β‐cell cytotoxicity is linked to formation of α‐sheet structure. Protein Science. 2024. doi:10.1002/pro.4854
BibTeX
@article{Hsu2024,
author = {Hsu, Cheng-Chieh and Templin, Andrew T and Prosswimmer, Tatum and Shea, Dylan and Li, Jinzheng and Brooks-Worrell, Barbara and Kahn, Steven E and Daggett, Valerie},
title = {Human islet amyloid polypeptide‐induced β‐cell cytotoxicity is linked to formation of α‐sheet structure},
journal = {Protein Science},
year = {2024},
doi = {10.1002/pro.4854}
}
EUVIMED